Chronic Granulomatous Disease as Differential Diagnosis to Crohn’s Disease in Children: a Case Report
DOI:
https://doi.org/10.2340/actadv.v104.40908Keywords:
Chronic Granulomatous Disease, Crohn's diseaseAbstract
Abstract is missing (Short communication)
Downloads
References
Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363: 2600-2610.
https://doi.org/10.1056/NEJMoa1007097 DOI: https://doi.org/10.1056/NEJMoa1007097
Peixoto A, Coelho R, Maia T, Sarmento A, Magro F, Macedo G. Chronic granulomatous disease mimicking colonic Crohn's disease successfully treated with infliximab. ACG Case Rep J 2017; 4: e46.
https://doi.org/10.14309/crj.2017.46 DOI: https://doi.org/10.14309/crj.2017.46
Barbato M, Ragusa G, Civitelli F, Marcheggiano A, Di Nardo G, Iacobini M, et al. Chronic granulomatous disease mimicking early-onset Crohn's disease with cutaneous manifestations. BMC Pediatr 2014; 14: 156-159.
https://doi.org/10.1186/1471-2431-14-156 DOI: https://doi.org/10.1186/1471-2431-14-156
Kammermeier J, Lamb CA, Jones KDJ, Anderson CA, Baple EL, Bolton C, et al. Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition. Lancet Gastroenterol Hepatol 2023; 8: 271-286.
https://doi.org/10.1016/S2468-1253(22)00337-5 DOI: https://doi.org/10.1016/S2468-1253(22)00337-5
Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatr Infect Dis Soc 2018; 7(Suppl 1): S2-5.
https://doi.org/10.1093/jpids/piy008 DOI: https://doi.org/10.1093/jpids/piy008
LaBere B, Gutierrez MJ, Wright H, Garabedian E, Ochs HD, Fuleihan RL, et al. Chronic granulomatous disease with inflammatory bowel disease: clinical presentation, treatment, and outcomes from the USIDNET Registry. J Allergy Clin Immunol Pract 2022; 10: 1325-1333.
https://doi.org/10.1016/j.jaip.2021.12.035 DOI: https://doi.org/10.1016/j.jaip.2021.12.035
Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis Off Publ Infect Dis Soc Am 2010; 51: 1429-1434.
https://doi.org/10.1086/657308 DOI: https://doi.org/10.1086/657308
Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, et al. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a Primary Immune Deficiency Treatment Consortium study. J Allergy Clin Immunol 2024; 153: 1423-1431.
https://doi.org/10.1016/j.jaci.2024.01.013 DOI: https://doi.org/10.1016/j.jaci.2024.01.013
Gennery AR. Progress in treating chronic granulomatous disease. Br J Haematol 2021; 192: 251-264.
https://doi.org/10.1111/bjh.16939 DOI: https://doi.org/10.1111/bjh.16939
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Victor Coste, Thomas Guillaume, Marlène Chotard, Nathalie Cheikh, François Aubin, Eve Puzenat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.